US 8592379
Metastin derivative and use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 8592379 (Metastin derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61P, A61P1/18, A61P15/00